Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources

INTRODUCTION: The aim of this study was to use multiple data sources to update information on gastrointestinal perforations (GIPs) during tocilizumab (TCZ) treatment in patients with rheumatoid arthritis (RA). METHODS: Reporting rates of GIP events were estimated from three distinct patient data set...

Descripción completa

Detalles Bibliográficos
Autores principales: Monemi, Sharareh, Berber, Erhan, Sarsour, Khaled, Wang, Jianmei, Lampl, Kathy, Bharucha, Kamal, Pethoe-Schramm, Attila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127961/
https://www.ncbi.nlm.nih.gov/pubmed/27747579
http://dx.doi.org/10.1007/s40744-016-0037-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127961/
https://www.ncbi.nlm.nih.gov/pubmed/27747579
http://dx.doi.org/10.1007/s40744-016-0037-z

Ejemplares similares